DPP4i sitagliptin reduces Aß levels, restores IDE expression and decreases tau hyperphosphorylation in HFD/STZ induced-T2D mice [208], but exacerbates tau phosphorylation in Otsuka Long Evans Tokushima Fatty rats [224]. Here, MAPT is linked to type 2 diabetes mellitus.